The controversy over long-acting beta agonists: Examining the evidence

Article Type

Article

Changed

Wed, 08/22/2018 - 11:58

Display Headline

The controversy over long-acting beta agonists: Examining the evidence

Author(s)

David M. Lang, MD

Article PDF

content_73_973.pdf

Author and Disclosure Information

David M. Lang, MD
Head, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: David M. Lang, MD, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail langd@ccf.org

Dr. Lang has disclosed that he has received honoraria, consulting fees, or other benefits for teaching, speaking, consulting, or conducting research for the AstraZeneca, Centocor, Critical Therapeutics, Genentech, Novartis, GlaxoSmithKline, MedPointe, Merck, Sanofi-Aventis, and Schering-Plough/Key corporations.

Issue

Cleveland Clinic Journal of Medicine - 73(11)

Publications

Cleveland Clinic Journal of Medicine

Topics

Immunology

Pulmonology

Drug Therapy

Page Number

973-976, 978, 981-984, 986, 989, 992

Sections

Current Drug Therapy

Author(s)

David M. Lang, MD

Author(s)

David M. Lang, MD

Author and Disclosure Information

David M. Lang, MD
Head, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: David M. Lang, MD, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail langd@ccf.org

Dr. Lang has disclosed that he has received honoraria, consulting fees, or other benefits for teaching, speaking, consulting, or conducting research for the AstraZeneca, Centocor, Critical Therapeutics, Genentech, Novartis, GlaxoSmithKline, MedPointe, Merck, Sanofi-Aventis, and Schering-Plough/Key corporations.

Author and Disclosure Information

David M. Lang, MD
Head, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: David M. Lang, MD, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail langd@ccf.org

Dr. Lang has disclosed that he has received honoraria, consulting fees, or other benefits for teaching, speaking, consulting, or conducting research for the AstraZeneca, Centocor, Critical Therapeutics, Genentech, Novartis, GlaxoSmithKline, MedPointe, Merck, Sanofi-Aventis, and Schering-Plough/Key corporations.

Article PDF

content_73_973.pdf

Article PDF

content_73_973.pdf

Issue

Cleveland Clinic Journal of Medicine - 73(11)

Issue

Cleveland Clinic Journal of Medicine - 73(11)

Page Number

973-976, 978, 981-984, 986, 989, 992

Page Number

973-976, 978, 981-984, 986, 989, 992